Navigation Links
Frost & Sullivan Acknowledges Euro Diagnostica AB's Excellence in Product Differentiation
Date:4/30/2013

LONDON, April 30, 2013 /PRNewswire/ -- Based on its recent analysis of the autoimmune disease diagnostics market, Frost & Sullivan recognises Euro Diagnostica AB with the 2013 Europe Product Differentiation Excellence Award.

"Euro Diagnostica offers a range of high-quality enzyme linked immunosorbent assay (ELISA) kits for autoimmune diagnostics," noted Frost & Sullivan Senior Research Analyst Srinivas Sashidhar . "Together with world class scientists Euro Diagnostica has been the first to develop and produce the gold standard testing for autoantibodies to citrullinated proteins/peptide (anti-CCP autoantibodies) for rheumatoid arthritis through its anti-CCP2 ELISA kit Immunoscan CCPlus®."

In addition, Euro Diagnostica has been the first to develop anti-neutrophil cytoplasmic antibodies (ANCA) tests for diagnosing systemic vasculitis and related diseases. Wieslab® Capture ANCA ELISA is based on the capture technique developed by Euro Diagnostica to better optimise antigen presentation.

"Clinical evaluation of capture assays for determining PR3 ANCA shows that this format has a higher diagnostic sensitivity for detecting patients with potentially life threatening granulomatosis with polyangiitis (GPA), compared with the direct coating method or indirect immunofluorescence," remarked Sashidhar.

Another unique product line is the Euro Diagnostica complement test system, Wieslab® Complement ELISA that consists of functional assessments of all three pathways - classical, alternative and lectin - in a simple and accurate ELISA format. Assessment of the three pathways can be carried out with separate ELISA kits or in a combined kit.

Euro Diagnostica, as a partner of Dynex, has harmonised all ELISA tests to the DSX and DS2 platform. Earlier this year, the company also added EULISA tests to its existing product line for autoimmune diagnostics.

"All the diagnostic products developed by Euro Diagnostica are compatible and customised for clinical autoimmunology, microbiology, and immunochemistry laboratories," stated Sashidhar. "The Dynex instrument is an open and flexible diagnostic solution, which can be tailored for a range of autoimmune diseases, including localised and systemic diseases.

Additionally, Euro Diagnostica also offers top-quality, cost-effective customised coating services for the tests.  For example the ready-to-use ELISA EUwell Streptavidin plates, in-house developed and manufactured by Euro Diagnostica are optimised for coating and blocking volume and highest uniformity. Euro Diagnostica also develops and manufactures a number of unique purified antigens and antibodies.

"Euro Diagnostica's broad product portfolio successfully addresses the needs of its target market," said Sashidhar. "For instance, the harmonisation of the tests with the Dynex instruments and other similar ELISA robots shows that they meet demands pertaining to reproducibility and the linearity of results in line with the comparative tests."

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in developing products with unique features/functionality, quality/complexity, that support customisation and are matched to target markets needs. The company has also excelled in achieving superior brand perception of the uniqueness of its products.

Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Euro Diagnostica AB

Euro Diagnostica - a leader in autoimmunity testing provides complete diagnostic solutions and offers also customized coating services. Wieslab Lab Services, an integral part of Euro Diagnostica, offers testing services for most autoimmune diseases.

During the last two decades, our world class scientists have been the first to develop and produce top quality ELISA kits for ANCA, anti-CCP, Chromogranin and Complement assays, which are now in use all over the world.

Euro Diagnostica combines a long tradition in R&D with a commitment to quality. Euro Diagnostica's goal is to constantly develop solutions to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune and related diseases.

Euro Diagnostica AB
Lundavagen 151
SE-202 11 MALMO / Sweden

Else Beth Trautner , CEO
Tel: +46 40 53 76 85
ElseBeth.Trautner@eurodiagnostica.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:
Emily Bailey
Best Practices
Frost & Sullivan
emily.bailey@frost.com
P: +44 (0)20 7915 7869
www.frost.com

 

 

 


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Government Incentives Spur Adoption of Computed Tomography, Magnetic Resonance Imaging and Ultrasound Systems in Brazil, Finds Frost & Sullivan
2. Frost & Sullivan: More than 10 Million U.S. Patients Treatable by Neurostimulation, Driving Uptake
3. Image-guided and Robot-assisted Surgery Markets in Western Europe Set for Strong Expansion, says Frost & Sullivan
4. Frost & Sullivan Recognized Top Industry Innovators
5. Frost & Sullivan: Government Initiatives Drive Use of Electronic Medical and Health Records in Asia-Pacific
6. Frost & Sullivan Company of the Year Award Conferred on Medtech SAS
7. Frost & Sullivan Announces Award Categories for 2013 Malaysia Excellence Awards
8. Frost & Sullivan Confers 2013 South Africa Market Share Leadership Award on Shimadzu Corporation
9. Frost & Sullivan: Growing Reimbursement Challenges Force Hospitals to Reengineer Revenue Cycle Management
10. Western European Endoscopic Devices Market to Benefit from Increase in Minimally Invasive Surgeries, Says Frost & Sullivan
11. Advances in Surgical Technologies Boost Demand for Efficient Bone Graft Substitutes, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
(Date:5/26/2016)... , May 26, 2016 Since ... matured into an essential life science tool for conducting ... applications. BCC Research reveals in its new report that ... growth phase, one powered by a range of new ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
Breaking Medicine Technology:
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 ... ... transplantation, and one that has a significant negative impact on long-term patient survival, ... to date. The results, published online this week in the Journal of Thoracic ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... solutions for drugs, biologics, consumer health and global clinical supply services, today announced ... to support the company’s continued investment and strategic growth plans in the Asia ...
(Date:5/26/2016)... ... May 26, 2016 , ... In an effort to provide hair restoration information to the ... users and those who do not use the app. Dr. Mohebi, the founder of Parsa ... Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to the Snapchat ...
(Date:5/26/2016)... ... 26, 2016 , ... Eating Recovery Center, Washington ... a brand new child and adolescent residential treatment center on June 1. The ... more specialized eating disorder treatment and access to life-saving care. , To celebrate, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Nike Yoga Camps at ... daily practices, arts & crafts, discussions, and games all geared towards enhancing your ... have combined backgrounds in kids’ yoga, collegiate sport yoga instruction, and global yoga ...
Breaking Medicine News(10 mins):